SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN) Fundamental Analysis & Valuation

NYSE:SOMN • US8425878423

Current stock price

50.4 USD
-0.68 (-1.33%)
Last:

This SOMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SOMN Profitability Analysis

1.1 Basic Checks

  • In the past year SOMN was profitable.
  • In the past year SOMN had a positive cash flow from operations.
  • SOMN had positive earnings in each of the past 5 years.
  • SOMN had a positive operating cash flow in each of the past 5 years.
SOMN Yearly Net Income VS EBIT VS OCF VS FCFSOMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B

1.2 Ratios

  • The Return On Assets of SOMN (2.79%) is comparable to the rest of the industry.
  • SOMN has a better Return On Equity (12.05%) than 74.47% of its industry peers.
  • With a decent Return On Invested Capital value of 4.30%, SOMN is doing good in the industry, outperforming 63.83% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SOMN is in line with the industry average of 4.52%.
  • The 3 year average ROIC (4.15%) for SOMN is below the current ROIC(4.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.79%
ROE 12.05%
ROIC 4.3%
ROA(3y)2.89%
ROA(5y)2.63%
ROE(3y)12.65%
ROE(5y)11.61%
ROIC(3y)4.15%
ROIC(5y)4%
SOMN Yearly ROA, ROE, ROICSOMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 14.69%, SOMN is in the better half of the industry, outperforming 63.83% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SOMN has remained more or less at the same level.
  • SOMN's Operating Margin of 24.65% is fine compared to the rest of the industry. SOMN outperforms 72.34% of its industry peers.
  • In the last couple of years the Operating Margin of SOMN has remained more or less at the same level.
  • With an excellent Gross Margin value of 88.95%, SOMN belongs to the best of the industry, outperforming 82.98% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SOMN has remained more or less at the same level.
Industry RankSector Rank
OM 24.65%
PM (TTM) 14.69%
GM 88.95%
OM growth 3Y7.89%
OM growth 5Y-0.48%
PM growth 3Y6.87%
PM growth 5Y-0.82%
GM growth 3Y2.36%
GM growth 5Y-0.17%
SOMN Yearly Profit, Operating, Gross MarginsSOMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

0

2. SOMN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SOMN is destroying value.
  • The number of shares outstanding for SOMN remains at a similar level compared to 1 year ago.
  • SOMN has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SOMN has a worse debt to assets ratio.
SOMN Yearly Shares OutstandingSOMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SOMN Yearly Total Debt VS Total AssetsSOMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 0.72, we must say that SOMN is in the distress zone and has some risk of bankruptcy.
  • SOMN has a Altman-Z score of 0.72. This is in the lower half of the industry: SOMN underperforms 65.96% of its industry peers.
  • SOMN has a Debt/Equity ratio of 1.84. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of SOMN (1.84) is worse than 80.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.74
WACC5.83%
SOMN Yearly LT Debt VS Equity VS FCFSOMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.65 indicates that SOMN may have some problems paying its short term obligations.
  • SOMN has a Current ratio of 0.65. This is in the lower half of the industry: SOMN underperforms 70.21% of its industry peers.
  • SOMN has a Quick Ratio of 0.65. This is a bad value and indicates that SOMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of SOMN (0.45) is worse than 74.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.45
SOMN Yearly Current Assets VS Current LiabilitesSOMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

5

3. SOMN Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.91% over the past year.
  • SOMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.76% yearly.
  • SOMN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.58%.
  • SOMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.72% yearly.
EPS 1Y (TTM)5.91%
EPS 3Y6%
EPS 5Y5.76%
EPS Q2Q%10%
Revenue 1Y (TTM)10.58%
Revenue growth 3Y0.31%
Revenue growth 5Y7.72%
Sales Q2Q%10.09%

3.2 Future

  • Based on estimates for the next years, SOMN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.00% on average per year.
  • SOMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.80% yearly.
EPS Next Y9.42%
EPS Next 2Y8.55%
EPS Next 3Y8.64%
EPS Next 5Y8%
Revenue Next Year8.18%
Revenue Next 2Y6.87%
Revenue Next 3Y6.63%
Revenue Next 5Y6.8%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SOMN Yearly Revenue VS EstimatesSOMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B
SOMN Yearly EPS VS EstimatesSOMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

6

4. SOMN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.72, which indicates a very decent valuation of SOMN.
  • Based on the Price/Earnings ratio, SOMN is valued a bit cheaper than the industry average as 72.34% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, SOMN is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 10.71, the valuation of SOMN can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SOMN indicates a rather cheap valuation: SOMN is cheaper than 80.85% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, SOMN is valued rather cheaply.
Industry RankSector Rank
PE 11.72
Fwd PE 10.71
SOMN Price Earnings VS Forward Price EarningsSOMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • SOMN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SOMN is cheaper than 72.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.6
SOMN Per share dataSOMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • SOMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of SOMN may justify a higher PE ratio.
PEG (NY)1.24
PEG (5Y)2.04
EPS Next 2Y8.55%
EPS Next 3Y8.64%

4

5. SOMN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.12%, SOMN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.79, SOMN pays a bit more dividend than its industry peers.
  • SOMN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.12%

5.2 History

  • The dividend of SOMN has a limited annual growth rate of 2.35%.
  • SOMN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)2.35%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 69.45% of the earnings are spent on dividend by SOMN. This is not a sustainable payout ratio.
  • SOMN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP69.45%
EPS Next 2Y8.55%
EPS Next 3Y8.64%
SOMN Yearly Income VS Free CF VS DividendSOMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B
SOMN Dividend Payout.SOMN Dividend Payout, showing the Payout Ratio.SOMN Dividend Payout.PayoutRetained Earnings

SOMN Fundamentals: All Metrics, Ratios and Statistics

SOUTHERN CO - SO 7 1/8 12/15/28

NYSE:SOMN (4/24/2026, 8:09:03 PM)

50.4

-0.68 (-1.33%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners72.64%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap56.82B
Revenue(TTM)29.55B
Net Income(TTM)4.34B
Analysts71.25
Price Target54.5 (8.13%)
Short Float %0.09%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield 3.12%
Yearly Dividend2.74
Dividend Growth(5Y)2.35%
DP69.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.9%
Min EPS beat(2)-6.91%
Max EPS beat(2)3.1%
EPS beat(4)1
Avg EPS beat(4)-1.04%
Min EPS beat(4)-6.91%
Max EPS beat(4)3.1%
EPS beat(8)4
Avg EPS beat(8)2.67%
EPS beat(12)8
Avg EPS beat(12)3.33%
EPS beat(16)11
Avg EPS beat(16)4.23%
Revenue beat(2)1
Avg Revenue beat(2)2.15%
Min Revenue beat(2)-0.17%
Max Revenue beat(2)4.47%
Revenue beat(4)3
Avg Revenue beat(4)4.34%
Min Revenue beat(4)-0.17%
Max Revenue beat(4)7.77%
Revenue beat(8)5
Avg Revenue beat(8)2.53%
Revenue beat(12)6
Avg Revenue beat(12)-2.95%
Revenue beat(16)10
Avg Revenue beat(16)2.77%
PT rev (1m)-2.49%
PT rev (3m)-3.2%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)-4.35%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)3.58%
Valuation
Industry RankSector Rank
PE 11.72
Fwd PE 10.71
P/S 1.92
P/FCF N/A
P/OCF 5.8
P/B 1.58
P/tB 1.86
EV/EBITDA 9.6
EPS(TTM)4.3
EY8.53%
EPS(NY)4.71
Fwd EY9.34%
FCF(TTM)-2.6
FCFYN/A
OCF(TTM)8.7
OCFY17.25%
SpS26.21
BVpS31.95
TBVpS27.1
PEG (NY)1.24
PEG (5Y)2.04
Graham Number55.5973 (10.31%)
Profitability
Industry RankSector Rank
ROA 2.79%
ROE 12.05%
ROCE 5.25%
ROIC 4.3%
ROICexc 4.36%
ROICexgc 4.53%
OM 24.65%
PM (TTM) 14.69%
GM 88.95%
FCFM N/A
ROA(3y)2.89%
ROA(5y)2.63%
ROE(3y)12.65%
ROE(5y)11.61%
ROIC(3y)4.15%
ROIC(5y)4%
ROICexc(3y)4.19%
ROICexc(5y)4.04%
ROICexgc(3y)4.37%
ROICexgc(5y)4.23%
ROCE(3y)5.09%
ROCE(5y)4.91%
ROICexgc growth 3Y3.03%
ROICexgc growth 5Y2.27%
ROICexc growth 3Y3.28%
ROICexc growth 5Y2.54%
OM growth 3Y7.89%
OM growth 5Y-0.48%
PM growth 3Y6.87%
PM growth 5Y-0.82%
GM growth 3Y2.36%
GM growth 5Y-0.17%
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF N/A
Debt/EBITDA 4.98
Cap/Depr 211.23%
Cap/Sales 43.1%
Interest Coverage 2.71
Cash Conversion 73.62%
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.45
Altman-Z 0.72
F-Score4
WACC5.83%
ROIC/WACC0.74
Cap/Depr(3y)187.9%
Cap/Depr(5y)188.18%
Cap/Sales(3y)37.54%
Cap/Sales(5y)34.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.91%
EPS 3Y6%
EPS 5Y5.76%
EPS Q2Q%10%
EPS Next Y9.42%
EPS Next 2Y8.55%
EPS Next 3Y8.64%
EPS Next 5Y8%
Revenue 1Y (TTM)10.58%
Revenue growth 3Y0.31%
Revenue growth 5Y7.72%
Sales Q2Q%10.09%
Revenue Next Year8.18%
Revenue Next 2Y6.87%
Revenue Next 3Y6.63%
Revenue Next 5Y6.8%
EBIT growth 1Y3.38%
EBIT growth 3Y8.23%
EBIT growth 5Y7.2%
EBIT Next Year83.92%
EBIT Next 3Y30.23%
EBIT Next 5Y20.51%
FCF growth 1Y-452.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.14%
OCF growth 3Y15.86%
OCF growth 5Y7.92%

SOUTHERN CO - SO 7 1/8 12/15/28 / SOMN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOUTHERN CO - SO 7 1/8 12/15/28?

ChartMill assigns a fundamental rating of 4 / 10 to SOMN.


What is the valuation status of SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN). This can be considered as Fairly Valued.


Can you provide the profitability details for SOUTHERN CO - SO 7 1/8 12/15/28?

SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN) has a profitability rating of 7 / 10.


What are the PE and PB ratios of SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN) stock?

The Price/Earnings (PE) ratio for SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN) is 11.72 and the Price/Book (PB) ratio is 1.58.


How financially healthy is SOUTHERN CO - SO 7 1/8 12/15/28?

The financial health rating of SOUTHERN CO - SO 7 1/8 12/15/28 (SOMN) is 0 / 10.